Position in LEGN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$8,565,403
+$3,121,073 QoQ
Shares Held
296,586
-1.5% QoQ
Ownership
0.152%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#39
of 217 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LEGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Empire Life Investments Inc. holds $27,170,981 across 5 Biotechnology names. LEGN ranks #1 (31.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LEGN |
Legend Biotech Corp
This page
|
296,586 | $8,565,403 | |
| 2 | OCUL |
Ocular Therapeutix, Inc
|
871,692 | $8,560,015 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
12,640 | $3,805,019 | |
| 4 | SPRY |
ARS Pharmaceuticals, Inc.
|
471,856 | $3,779,566 | |
| 5 | ARCT |
Arcturus Therapeutics Holdings Inc.
|
366,217 | $2,460,978 |
All Filings in LEGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,565,403 | 296,586 | Shares | Defined | 2026-07-24 | |
| 2026-03-31 | $5,444,330 | 300,958 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $7,020,628 | 322,936 | Shares | Defined | 2026-02-04 | |
| 2025-09-30 | $10,598,510 | 325,008 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $9,863,629 | 277,927 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,620,877 | 165,661 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $4,449,226 | 136,731 | Shares | Defined | 2025-01-30 | |
| 2024-09-30 | $4,809,066 | 98,688 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $2,494,412 | 56,320 | Shares | Defined | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||